Bioteque Stock Forecast for 2023 - 2025 - 2030
Updated on 04/28/2024
Bioteque Stock Forecast and Price Target
The average price target for Bioteque's stock lately set by several renowned analysts is NT$50.44, which would result in a potential downside of approximately -59.16% if it reaches this mark by December 31, 2024. This estimation is based on a high estimate of NT$56.50 and a low estimate of NT$44.90. If you are interested in 4107 stock, it is important to also consider its competitors.
-59.16% Downside
Bioteque Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Bioteque has seen a decline in its Price, from NT$128.54 to NT$0.00 – a 100.00% decrease. In the next year, analysts expect Fair Value to reach NT$100.89 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 4126 Stock Forecast | Pacific Hospital Supply | Outperform |
18
|
NT$91.00 | Buy/Sell | NT$94.50 | 5.49% |
| 4106 Stock Forecast | Wellell | - |
17
|
NT$28.90 | Buy/Sell | NT$0.00 | -100.00% |
| 6730 Stock Forecast | Lagis Enterprise | - |
16
|
NT$38.60 | Buy/Sell | NT$0.00 | -100.00% |
| 6767 Stock Forecast | Wiltrom | - |
7
|
NT$40.50 | Buy/Sell | NT$0.00 | -100.00% |
| 6662 Stock Forecast | BioLASCO Taiwan | - |
0
|
NT$35.65 | Buy/Sell | NT$0.00 | -100.00% |
Bioteque Revenue Forecast for 2023 - 2025 - 2030
Bioteque's Revenue has increased by 3.21% In the last two years, going from NT$1.95B to NT$2.01B. According to the 0 analysts polled, in the next year, Bioteque's Revenue will fall by 3.90%, reaching NT$1.93B. By 2030, professionals believe that Bioteque's Revenue will have decreased by 3.89%, falling to NT$1.93B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 1781 Stock Forecast | Health & Life | - |
0
|
NT$17.80 | Buy/Sell | NT$0.00 | -100.00% |
| 6633 Stock Forecast | Somnics | - |
0
|
NT$11.75 | Buy/Sell | NT$0.00 | -100.00% |
| 6758 Stock Forecast | A-SPINE Asia | - |
0
|
40.50 | Buy/Sell | 0.00 | -100.00% |
.jpg)
Bioteque Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Bioteque's Dividend per Share has grown, increasing from NT$4.00 to NT$4.50 – a growth of 12.50%. For the next year, 0 analysts project Bioteque's Dividend per Share to drop by 3.70%, reaching NT$4.33. By 2030, professionals believe that Bioteque's Dividend per Share will decrease by 3.58%, reaching NT$4.34 – a concerning trend for the company.
Bioteque EBITDA Forecast for 2023 - 2025 - 2030
Bioteque's EBITDA has decreased In the last two years, from NT$710.97M to NT$698.87M – a 1.70% drop. In the following year, 0 experts forecast Bioteque's EBITDA will decrease by 1.03%, to NT$691.69M. In 2030, professionals predict that Bioteque's EBITDA will decrease by 1.09%, to NT$691.28M.
Bioteque EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Bioteque's EBIT has seen a drop from NT$606.72M to NT$578.38M – a 4.67% decrease. For next year, analysts predict EBIT of NT$578.78M, which would mean an increase of 0.07%. Professionals believe that By 2030, Bioteque's EBIT will fall to NT$578.30M– a 0.01% decrease from its current value.
Bioteque EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Bioteque has seen a decline in its EPS, from NT$7.02 to NT$0.00 – a 100.00% decrease. In the next year, analysts expect EPS to reach NT$5.51 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
.jpg)